Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark W. Russo

Showing results (111-120 of 129) with videos related to

Pageof 13
Sort By:
Digestive Diseases and Sciences|January 14, 2018
Analysis of Plasma Tenascin-C in Post-HCV Cirrhosis: A Prospective StudyJennifer H Benbow, April D Elam, Krista L Bossi, et al.
European Journal of Clinical Pharmacology|October 3, 2009
Population pharmacokinetics of intravenous ondansetron in oncology and surgical patients aged 1-48 monthsJohn T Mondick, Brendan M Johnson, Lynda J Haberer, et al.
Journal of Proteomics|September 3, 2010
Discovery of putative pancreatic cancer biomarkers using subcellular proteomicsKimberly Q McKinney, Yong-Yook Lee, Hyun-Su Choi, et al.
The American Journal of Gastroenterology|August 28, 2004
Interferon alfa-2b [correction of alpha-2b]and ribavirin for patients with chronic hepatitis C and normal ALTIra M Jacobson, Furqaan Ahmed, Mark W Russo, et al.
The American Journal of Pathology|November 26, 2015
Diet-Induced Obesity Enhances Progression of Hepatocellular Carcinoma through Tenascin-C/Toll-Like Receptor 4 SignalingJennifer H Benbow, Kyle J Thompson, Heidi L Cope, et al.
Journal of Proteome Research|September 15, 2011
Subcellular tissue proteomics of hepatocellular carcinoma for molecular signature discoveryYong-Yook Lee, Kimberly Q McKinney, Sriparna Ghosh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 8, 2019
Efficacy and Safety of Dabrafenib in Pediatric Patients with <i>BRAF</i> V600 Mutation-Positive Relapsed or Refractory Low-Grade Glioma: Results from a Phase I/IIa StudyDarren R Hargrave, Eric Bouffet, Uri Tabori, et al.
Annals of Hepatology|December 15, 2011
Region 11 MELD Na exception prospective studyRobert A Fisher, Douglas M Heuman, Ann M Harper, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 20, 2013
Randomized trial of lapatinib versus placebo added to paclitaxel in the treatment of human epidermal growth factor receptor 2-overexpressing metastatic breast cancerZhongzhen Guan, Binghe Xu, Michelle L DeSilvio, et al.
Anesthesia and Analgesia|July 23, 2005
A double-blind comparison of intravenous ondansetron and placebo for preventing postoperative emesis in 1- to 24-month-old pediatric patients after surgery under general anesthesiaSamia N Khalil, Andrew G Roth, Ira T Cohen, et al.
Pageof 13

Showing results (111-120 of 129) with videos related to

Sort By:
Pageof 13
Digestive Diseases and Sciences|January 14, 2018
Analysis of Plasma Tenascin-C in Post-HCV Cirrhosis: A Prospective StudyJennifer H Benbow, April D Elam, Krista L Bossi, et al.
European Journal of Clinical Pharmacology|October 3, 2009
Population pharmacokinetics of intravenous ondansetron in oncology and surgical patients aged 1-48 monthsJohn T Mondick, Brendan M Johnson, Lynda J Haberer, et al.
Journal of Proteomics|September 3, 2010
Discovery of putative pancreatic cancer biomarkers using subcellular proteomicsKimberly Q McKinney, Yong-Yook Lee, Hyun-Su Choi, et al.
The American Journal of Gastroenterology|August 28, 2004
Interferon alfa-2b [correction of alpha-2b]and ribavirin for patients with chronic hepatitis C and normal ALTIra M Jacobson, Furqaan Ahmed, Mark W Russo, et al.
The American Journal of Pathology|November 26, 2015
Diet-Induced Obesity Enhances Progression of Hepatocellular Carcinoma through Tenascin-C/Toll-Like Receptor 4 SignalingJennifer H Benbow, Kyle J Thompson, Heidi L Cope, et al.
Journal of Proteome Research|September 15, 2011
Subcellular tissue proteomics of hepatocellular carcinoma for molecular signature discoveryYong-Yook Lee, Kimberly Q McKinney, Sriparna Ghosh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 8, 2019
Efficacy and Safety of Dabrafenib in Pediatric Patients with <i>BRAF</i> V600 Mutation-Positive Relapsed or Refractory Low-Grade Glioma: Results from a Phase I/IIa StudyDarren R Hargrave, Eric Bouffet, Uri Tabori, et al.
Annals of Hepatology|December 15, 2011
Region 11 MELD Na exception prospective studyRobert A Fisher, Douglas M Heuman, Ann M Harper, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 20, 2013
Randomized trial of lapatinib versus placebo added to paclitaxel in the treatment of human epidermal growth factor receptor 2-overexpressing metastatic breast cancerZhongzhen Guan, Binghe Xu, Michelle L DeSilvio, et al.
Anesthesia and Analgesia|July 23, 2005
A double-blind comparison of intravenous ondansetron and placebo for preventing postoperative emesis in 1- to 24-month-old pediatric patients after surgery under general anesthesiaSamia N Khalil, Andrew G Roth, Ira T Cohen, et al.
Pageof 13